Multicentre, open, noncomparative Phase II trial to evaluate the efficacy and tolerability of fotemustine, cisplatin, alpha-interferon and interleukin-2 in advanced melanoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples